• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Evaluation of RT-PCR assays for detection of SARS-CoV-2 variants of concern

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Feb 9;13(1):2342.
doi: 10.1038/s41598-023-28275-y.
Evaluation of RT-PCR assays for detection of SARS-CoV-2 variants of concern


Sourav Dutta Dip[SUP] #[/SUP][SUP] 1 [/SUP], Shovon Lal Sarkar[SUP] #[/SUP][SUP] 1 [/SUP], Md Ali Ahasan Setu[SUP] 1 [/SUP], Prosanto Kumar Das[SUP] 1 [/SUP], Md Hasan Ali Pramanik[SUP] 1 [/SUP], A S M Rubayet Ul Alam[SUP] 1 [/SUP], Hassan M Al-Emran[SUP] 2 [/SUP], M Anwar Hossain[SUP] 3 4 [/SUP], Iqbal Kabir Jahid[SUP] 5 6 [/SUP]



Affiliations

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic has been considered with great importance on correct screening procedure. The detection efficiency of recent variants of concern were observed by comparing 5 commercial RT-PCR kits and a SYBR-green method developed and validated in our laboratory. The RNA was extracted from nasopharyngeal samples from suspected COVID-19 patients and RT-PCR assay was performed according to the instruction of the respective manufacturers. The specificity and sensitivity of Maccura kit was 81.8% and 82.5%, A*Star kit was 100% and 75.4%, Da An Gene kit was 100% and 68.4%, Sansure kit was 54.5% and 91.2% and TaqPath kit was 100% and 70.2% respectively. Our in house SYBR-Green method showed a consistent detection result with 90.9% specificity and 91.2% sensitivity. We also found that detection kits targeting more genes showed better accuracy which facilitates less false positive results (< 20%). Our study found a significant difference (p < 0.005) in Ct value reported for common target genes shared by the RT-PCR kits in relation with different variants of COVID-19 infection. Recent variants of concerns contain more than 30 mutations in the spike proteins including 2 deletion and a unique insertion mutation by which makes detection of these variants difficult and these facilitates the variants to escape from being detected.
 
Back
Top Bottom